Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1094 Articles

Jon C. Ogg | Dec 18, 2018 at 9:20 AM EST

Boeing and J&J Both Offer New Incentives for Investors After Big Losses

These two members of the thirty Dow Jones industrial average index have been under siege and are now fighting back.

Chris Lange | Dec 14, 2018 at 11:35 AM EST

Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder

Johnson & Johnson shares dropped on Friday after it came public that the company knew for decades that its baby…

Jon C. Ogg | Nov 27, 2018 at 6:45 AM EST

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019…

Jon C. Ogg | Nov 7, 2018 at 11:00 AM EST

After the Midterm Elections, 10 Defensive Stocks to Buy for 2019

These 10 companies that are likely to have safer business models and will offer some defensive positioning if the economic…

Chris Lange | Oct 16, 2018 at 8:35 AM EDT

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

Johnson & Johnson reported better-than-expected third-quarter financial results before the markets opened on Thursday.

Chris Lange | Oct 15, 2018 at 10:15 AM EDT

What to Expect When Johnson & Johnson Reports Tuesday

Johnson & Johnson is scheduled to report its third-quarter financial results early Tuesday, and analysts expect solid growth on the…

Chris Lange | Oct 14, 2018 at 7:10 AM EDT

Goldman Sachs, IBM, Amex and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of Johnson & Johnson, Procter & Gamble and the other Dow Jones…

Chris Lange | Oct 4, 2018 at 11:40 AM EDT

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of…

Paul Ausick | Sep 25, 2018 at 4:01 PM EDT

Intel, UnitedHealth Sink the Dow Tuesday

Intel, UnitedHealth, Johnson & Johnson, and 3M Company led the Dow's Tuesday drop.

Paul Ausick | Sep 5, 2018 at 4:01 PM EDT

Visa, Microsoft Hold Back the Dow Wednesday

Trading in the Dow 30 stocks was essentially flat Wednesday with Visa and Microsoft the leading losers while Caterpillar and…

Paul Ausick | Aug 20, 2018 at 4:01 PM EDT

Nike, Johnson & Johnson Lift the Dow Monday

Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.

Jon C. Ogg | Aug 14, 2018 at 5:35 PM EDT

Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings

The more recent observations about Buffett's portfolio changes coming into mid-2018 have been quite different than many of the historic and traditional…

Jon C. Ogg | Aug 6, 2018 at 10:30 AM EDT

The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club

It may not happen overnight, and a solid market correction would almost certainly interfere, but there are many companies that…

Douglas A. McIntyre | Aug 3, 2018 at 6:20 AM EDT

After Apple, Attention Turns Back to Market Risks

The success of Apple has hidden a multitude of problems within the larger market. Can the market hold on to…

Paul Ausick | Jul 24, 2018 at 4:01 PM EDT

United Technologies, Chevron Juice the Dow Tuesday

United Technologies, Chevron, Exxon Mobil, and Johnson & Johnson posted the Dow's biggest daily gains Tuesday.

1 … 22 23 24 25 26 … 73

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Boeing and J&J Both Offer New Incentives for Investors After Big Losses

Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

After the Midterm Elections, 10 Defensive Stocks to Buy for 2019

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

What to Expect When Johnson & Johnson Reports Tuesday

Goldman Sachs, IBM, Amex and More Dow Stocks Reporting This Week

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Intel, UnitedHealth Sink the Dow Tuesday

Visa, Microsoft Hold Back the Dow Wednesday

Nike, Johnson & Johnson Lift the Dow Monday

Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings

The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club

After Apple, Attention Turns Back to Market Risks

United Technologies, Chevron Juice the Dow Tuesday

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Ray Dalio Warns U.S. Faces ‘Particularly Risky Period’ Between 2026 and 2028 Elections

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Boeing and J&J Both Offer New Incentives for Investors After Big Losses

Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

After the Midterm Elections, 10 Defensive Stocks to Buy for 2019

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

What to Expect When Johnson & Johnson Reports Tuesday

Goldman Sachs, IBM, Amex and More Dow Stocks Reporting This Week

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Intel, UnitedHealth Sink the Dow Tuesday

Visa, Microsoft Hold Back the Dow Wednesday

Nike, Johnson & Johnson Lift the Dow Monday

Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings

The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club

After Apple, Attention Turns Back to Market Risks

United Technologies, Chevron Juice the Dow Tuesday

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Ray Dalio Warns U.S. Faces ‘Particularly Risky Period’ Between 2026 and 2028 Elections

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts